Cancer-predisposing mutations that destabilize the BRCA1 structure likely to abolish the ability of BRCA1 for transcriptional activation[40]. Val1714Gly mutation abolishes the transcriptional activation by BRCA1 in yeast and mammalian cells [41, 42]. The gene discussed is BRCA1; the disease is cancer.